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OBJECTIVE: Large-volume paracentesis is a safe and effec-
tive means of treating patients with refractory ascites. How-
ever, there is limited information regarding the need for
ascitic fluid studies in asymptomatic outpatients presenting
for therapeutic paracentesis. The aim of this prospective
study was to define the incidence and natural history of
peritoneal fluid infection in asymptomatic outpatients un-
dergoing therapeutic paracentesis.
METHODS: Over a 13-month period, 118 therapeutic para-
centeses were performed in 29 outpatients with decompen-
sated cirrhosis (Child-Pugh class B5 38%, C 5 62%).
After a brief medical history and physical examination,
ascitic fluid cell count with differential and culture were
obtained from all participating subjects. Seven (24%) of the
subjects were receiving norfloxacin prophylaxis, accounting
for antibiotic coverage during 40% of the procedures per-
formed. The clinical course and outcome of study subjects
during a mean follow-up of 137 days was reviewed.
RESULTS: All 118 (100%) of the ascitic fluid samples dem-
onstrated absolute neutrophil counts of,250/mm3 (mean5
6.5 6 22.5 pmn/mm3). Asymptomatic bacterascites was
identified from three of the 118 (2.5%) fluid samples, but all
of these subjects spontaneously recovered without treatment
or sequelae. During follow-up, six episodes of symptomatic
or hospital-associated peritoneal fluid infection were iden-
tified in study participants, emphasizing the importance of
fluid studies in other clinical settings.
CONCLUSIONS: Although further studies are needed, the
routine culture of ascitic fluid in asymptomatic outpatients
with refractory ascites requiring therapeutic paracentesis
may not be necessary when there is a low index of suspicion
for occult infection. In circumstances of clinical uncertainty,
however, obtaining ascitic fluid cell counts with differential
is recommended to insure patient safety. (Am J Gastroen-
terol 1999;94:2972–2976. © 1999 by Am. Coll. of Gastro-
enterology)
INTRODUCTION
Refractory ascites (RA), defined as fluid overload that is
unresponsive to sodium restriction and high-dose diuretics,
is estimated to occur in,10% of patients with cirrhotic
ascites (1). In light of the poor short-term survival in these
individuals, it is currently recommended that patients with
RA be considered for liver transplantation (2, 3). In both
transplant candidates and other patients with RA, intermit-
tent therapeutic large-volume paracentesis (LVP) is consid-
ered a safe, simple, and effective treatment strategy (3, 4).
Patients with advanced and severe liver disease such as
those with refractory ascites appear to be at increased risk of
developing peritoneal fluid infection (5). Although the out-
come with spontaneous bacterial peritonitis (SBP) and SBP
variants has improved over the last decade, the in-hospital
and 1-yr mortality of patients with SBP remain approxi-
mately 30% and 50%, respectively (6–8). At presentation,
as many as one-third of patients with infected peritoneal
fluid do not manifest overt signs or symptoms such as fever
or abdominal pain (6). Furthermore, 7–27% of patients with
cirrhotic ascites harbor occult peritoneal fluid infection at
the time of hospital admission (6, 9, 10). Therefore, a high
index of suspicion with a low threshold to perform a diag-
nostic paracentesis is required to make a rapid diagnosis of
this potentially life-threatening infection in various clinical
settings.
With an increasing emphasis on cost containment in the
delivery of medical care, many patients with RA are under-
going LVP in the outpatient setting. Although many of these
patients are at increased risk for SBP due to their advanced
liver disease, low protein ascites, and prior episode(s) of
SBP, the need for routine ascitic fluid analysis in the out-
patient setting remains unclear (11). The issue is further
complicated by the fact that some patients are now receiving
primary or secondary antibiotic prophylaxis to prevent SBP.
In our experience, there is considerable variability in clinical
practice with regards to the need and type of diagnostic
ascitic fluid studies to perform in the outpatient setting.
Therefore, the aim of this study was to prospectively deter-
mine the incidence and natural history of peritoneal fluid
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Outpatients with cirrhosis and RA presenting to the Medical
Procedure Unit at the University of Michigan Medical Cen-
ter for LVP were invited to participate in this study from
April 1, 1997 to May 15, 1998. A brief medical history and
physical exam was performed before each LVP by a gas-
troenterology fellow or attending physician. Inclusion cri-
teria were age$18 yr with diuretic refractory or intolerant
(i.e., develop prerenal azotemia or electrolyte imbalance)
cirrhotic ascites requiring therapeutic LVP. Exclusion cri-
teria included symptoms of possible peritonitis such as
recent fever, chills, or abdominal pain not thought to be
related to fluid accumulation alone. Subjects with moderate
to severe abdominal tenderness or peritoneal signs on ex-
amination were excluded. Other exclusion criteria included
evidence of acute decompensation in liver disease with
gastrointestinal bleeding, worsening hepatic encephalopa-
thy, or acute renal insufficiency with a serum creatinine
.2.5 mg/dl. In addition, subjects with malignant ascites and
noncirrhotic ascites were excluded. Any subject receiving
prescription antibiotics for a documented bacterial infection
within 2 wk of LVP were excluded. Subjects receiving oral
antibiotics for primary or secondary prophylaxis for SBP
were included. The protocol was reviewed by the local
Institutional Review Board and written informed consent
was obtained from all participating subjects.
During the study period, 227 outpatient paracenteses were
performed at our institution. Twenty-nine eligible subjects
were enrolled at the time of 118 therapeutic paracenteses
and form the basis of this report.
Procedure
Large-volume paracentesis was performed in the standard
fashion. A site in the midline suprapubic or lower quadrant
area was localized by percussion and prepped using sterile
technique. A 14-gauge catheter was inserted into the peri-
toneal cavity until a free flow of ascitic fluid was obtained.
The needle trocar was removed and fluid samples for diag-
nostic studies were obtained. The catheter was connected to
a wall-mounted suction unit with the intent to drain the
peritoneal cavity to the greatest extent possible, or total
paracentesis. In most instances, ascitic fluid was drained
within 30–90 min of needle insertion. Details of the proce-
dure, including the number of needle passes, fluid appear-
ance, volume removed, and complications, were prospec-
tively recorded. Immediate periprocedural complications
included hypotension, defined as a decrease in systolic
blood pressure of.20 mm Hg or a systolic blood pressure
,90 mm Hg upon completion of the procedure, intraperi-
toneal or site bleeding requiring transfusion or hospitaliza-
tion, new-onset abdominal pain, or leakage at the needle-
insertion site. Human serum albumin was infused per
predetermined dosing guidelines at the discretion of the
attending physician.
Laboratory test charges for ascitic fluid studies at the
University of Michigan Hospitals were obtained from the
Department of Laboratory Services. Estimates of the corre-
sponding Medicare reimbursement for the fluid studies per-
formed were obtained from published fee schedules for CPT
codes 89051 (fluid cell count with differential), 87075 (an-
aerobic culture), and 87070 (aerobic culture).
Ascitic Fluid Analysis
Using sterile technique, 10 ml of ascitic fluid was inoculated
at the bedside into Bactec-T/Alert FAN aerobic and anaer-
obic blood culture bottles (Organon Teknika, Durham, NC)
(12). Ascitic fluid cell counts with manual differential of the
white blood cell count was performed on all specimens
using standard laboratory techniques. Peritoneal fluid results
were categorized as follows: spontaneous bacterial perito-
nitis (SBP)5 fluid cell count of$250 polymorphonuclear
leukocytes (PMN)/mm3 with a positive culture; culture-
negative neutrocytic ascites (CNNA)5 fluid cell count of
$250 PMN/mm3 and a negative culture after 7 days; mo-
nomicrobial nonneutrocytic bacterascites (MNB)5 fluid
cell count of,250 PMN/mm3 and a single positive bacterial
culture result; normal or uninfected5 fluid cell count of
,250 PMN/mm3 and a negative culture after 7 days. All
subjects with MNB underwent repeat diagnostic paracente-
sis within 5 days of a positive culture report to detect
progression to SBP or resolution of bacterascites.
Subject Follow-Up
The cumulative incidence of peritoneal fluid infection and
the clinical outcome of study participants during the 13-
month study period were determined by chart review.
Statistics
Statistical analysis of the data was performed using Stat-
View 4.5 (Abacus Concepts Inc., Berkeley, CA). Values are
expressed as the mean6 SD.
RESULTS
Clinical characteristics of the 29 eligible subjects with re-
fractory cirrhotic ascites undergoing 118 therapeutic para-
centeses are summarized in Table 1. All subjects entered
into the protocol had a low ascitic fluid albumin and a
serum-ascites albumin gradient.1.1 g/dl (10). The etiology
of cirrhosis was related to alcohol and hepatitis C in the
majority of subjects. All subjects had evidence of advanced
liver disease with 38% Child-Pugh class B and 62% Child-
Pugh class C. In addition, 17% had a documented episode of
prior SBP and 38% were awaiting liver transplantation.
Overall, 24% of the subjects were receiving oral antibiotics
for primary or secondary prevention of SBP, accounting for
antibiotic coverage during 40% of the procedures per-
formed.
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The results from the 118 paracenteses with ascitic fluid
analysis are summarized in Table 2. Therapeutic paracen-
tesis was performed with the intent of total paracentesis
whenever possible. The procedure was well tolerated by
study subjects, with no serious complications identified. In
all cases, the fluid cell count was,250 PMN/mm3. Three of
the 118 fluid specimens grewMicrococcus, Klebsiella Oxy-
toca, and coagulase-negativeStaphylococcusspecies, re-
spectively. All of the positive cultures exhibited growth
within 4 days of inoculation. A careful review of the pro-
cedure notes failed to identify any technical difficulties
encountered during these procedures. Two of the three pos-
itive cultures occurred in a 47-yr-old man with cryptogenic
cirrhosis receiving norfloxacin 400 mg per day for primary
SBP prophylaxis. This patient underwent a total of 38 LVPs
over the study period. Subject follow-up after the report of
a positive culture included a repeat paracentesis with fluid
studies within 5 days. In each instance, the subject remained
asymptomatic and follow-up fluid studies revealed no evi-
dence of progressive or persistent infection.
The clinical course and outcome of the 29 study subjects
followed during the study period are summarized in Table 3.
With a mean follow-up of 1376 103 days, seven (24%)
subjects died, six (21%) underwent liver transplantation, 11
(38%) were alive at their last visit, and five (17%) were lost
to follow-up. The identified causes of death included hepa-
torenal syndrome in three subjects and progressive liver
failure in the remaining four. During follow-up, six subjects
(21%) developed discrete episodes of symptomatic perito-
neal fluid infection that were diagnosed under clinical cir-
cumstances independent of a study-related paracentesis.
Four cases of MNB and one case each of SBP and CNNA
were diagnosed immediately before or upon admission to
the hospital in patients with clinical symptoms (Table 3).
Only one of the six subjects was receiving prophylactic
antibiotics. All of these episodes of symptomatic peritoneal
fluid infection were successfully treated with antibiotics
without any associated in-hospital mortality. There was no
apparent temporal relationship between these episodes of
infection and the performance of an outpatient therapeutic
LVP.
The hospital charges and Medicare reimbursement for the
ascitic fluid cell counts and culture are summarized in Table
4. Assuming that the incidence of peritoneal fluid infection
is 2.5% in asymptomatic outpatients, the estimated cost to
diagnose a single case of monomicrobial bacterascites in a
comparable patient population would be $1320–$9600 us-
ing Medicare reimbursement and University of Michigan
Medical Center institutional charges, respectively.
DISCUSSION
Patients with refractory ascites are at increased risk of
developing potentially serious and life-threatening sponta-
neous peritoneal fluid infection, but little information re-
garding the need for routine ascitic fluid analysis at the time
of outpatient therapeutic paracentesis is available. We set
out to prospectively study ascitic fluid cell counts and cul-
tures obtained at the time of therapeutic LVP in outpatients
Table 1. Clinical Characteristics of Study Subjects (n5 29)
Mean age, yr 556 11.4 (range, 37–76 yr)
Gender 23 men, 6 women
Etiology of cirrhosis
Alcohol 12 (41.4%)
Alcohol and hepatitis C 6 (20.7%)






Transplant candidates 11 (38%)
Antibiotic prophylaxis 7 (24%)
Table 2. Ascitic Fluid Analysis at LVP (n5 118)
Mean no. of LVP/subject 4.16 7.5 (range, 1–36)
Mean volume removed 9.46 4.9 L (range, 2–20.8)
No. receiving albumin 103 (87%)
Mean albumin infused 24.26 16.0 g
Mean fluid WBC/mm3 1076 94.5/mm3 (range, 8–538/mm3)
Mean fluid PMN/mm3 6.56 22.5/mm3 (range, 0–204/mm3)
Positive cultures* 3 (2.5%)
* SeeResultsfor bacterial pathogens isolated.
LVP 5 large-volume paracentesis; WBC5 white blood cell count; PMN5
polymorphonuclear leukocytes.
Table 3. Ascitic Fluid Infection Identified at the Time of a Non-
study-related Paracentesis*
Infection† Presentation Culture Results
CNNA Fever, abdominal pain No growth
SBP Fever, abdominal pain Escherchia coli
MNB‡ Encephalopathy, N/V Streptococcus sp.
MNB At admission Serratia sp.
MNB Abdominal pain Staphylococcus sp.
MNB Fever, other infection Pseudomonas sp.
* Mean follow-up, 1376 103 days (range, 7–338).
† Additional episodes of ascitic fluid infection were identified under clinical
circumstances independent of a study-related outpatient therapeutic paracentesis.
‡ Receiving prophylactic antibiotics.
CNNA 5 culture-negative neutrocytic ascites; SBP5 spontaneous bacterial
peritonitis; MNB5 monomicrobial nonneutrocytic bacterascites; N/V5 nausea and
vomiting.
Table 4. Estimated Hospital Charges and Medicare
Reimbursement for Ascitic Fluid Studies
Ascitic Fluid Test UMMC* Medicare†
Fluid cell count with differential $ 92 $ 8
Fluid culture (aerobic/anaerobic) $ 148 $ 25
Total charge per procedure $ 240 $ 33
Cost per case of MNB identified
5 Total charge per procedure/
(2.5 case of MNB identified/
100 procedures)
$9600 $1320
* Charges estimated from University of Michigan Hospitals laboratory fee schedule.
† Medicare laboratory fee reimbursement for CPT codes 89051 (fluid cell count
with differential), 87075 (anaerobic culture), and 87070 (aerobic culture).
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with refractory ascites. We found that none of the 118 fluid
specimens demonstrated elevated neutrophil counts sugges-
tive of bacterial peritonitis. Furthermore, the bedside inoc-
ulation of blood culture bottles grew bacterial microorgan-
isms in only three of 118 (2.5%) samples. With fluid cell
counts of,250 PMN/mm3, these cases were classified as
MNB, an SBP variant with a more favorable prognosis than
SBP or CNNA (13, 14). Close monitoring of subjects with
MNB demonstrated spontaneous clearance of bacterascites
in all three cases. This favorable outcome in subjects with
asymptomatic MNB is consistent with prior studies that
demonstrate a favorable prognosis in the absence of symp-
toms (14, 15).
The low rate of peritoneal fluid infection observed in our
study may be due to several factors. Subjects with overt
signs or symptoms suggestive of peritoneal fluid infection,
acute decompensation in liver disease, and those being
admitted to the hospital for other reasons were excluded
from this protocol, as it is standard of care to perform a
diagnostic paracentesis in these high-risk settings (16). Sec-
ondly, antibiotic prophylaxis with norfloxacin was used by
24% of study subjects, accounting for antibiotic coverage
during 40% of the procedures performed. This may have
resulted in a lower-than-expected rate of peritoneal fluid
infection, as previous studies have demonstrated the efficacy
of antibiotic prophylaxis in high-risk patient populations
(17, 18).
It is unlikely that the low rate of peritoneal fluid infection
observed was due to suboptimal culture methods and tech-
niques. Ten milliliters of ascitic fluid was directly inoculated
into aerobic and anaerobic blood culture bottles at the bed-
side using sterile technique. This culture method has been
previously shown to be superior to standard culture methods
in the detection of ascitic fluid pathogens (12, 19). Con-
versely, highly sensitive culture techniques may theoreti-
cally overestimate the prevalence of true peritoneal fluid
infection due to growth of contaminants. The three cases of
bacterascites were classified as MNB, as prior reports have
identified the isolated microorganisms as potential patho-
gens (20). However, the clinical significance of a culture
growing coagulase-negativestaphylococci, a frequent skin
contaminant, remains unclear.
Despite the low incidence of peritoneal fluid infection at
the time of outpatient LVP, the study population represented
a high-risk group. All of the study subjects had RA, 62%
were Child-Pugh class C cirrhotics, and 17% had a prior
history of documented SBP. During a mean follow-up of
137 days, six subjects (21%) were diagnosed with symp-
tomatic SBP or SBP variants under clinical circumstances
independent of a study-related procedure (Table 3). Fortu-
nately, all six cases were successfully treated with antibiot-
ics without any associated in-hospital mortality. Nonethe-
less, overall mortality remained predictably high in our
study population, with only 55% of subjects surviving with-
out liver transplantation.
Only two other studies published in abstract form have
addressed the issue of whether ascitic fluid should be ana-
lyzed at the time of therapeutic paracentesis in asymptom-
atic outpatients (Table 5). In a retrospective study of 37
outpatient LVPs performed at Emory University, ascitic
fluid cell counts and cultures revealed no evidence of peri-
toneal fluid infection (21). Similarly, in a prospective study
from Barcelona, 173 ascitic fluid samples were analyzed
from 51 asymptomatic stable cirrhotics with RA (22). All
ascitic fluid cell counts were,250 PMN/mm3 and only four
ultures (2.3%) grew bacterial microorganisms. These in-
fections, classified as asymptomatic MNB, reportedly
cleared without treatment or sequelae. The incidence of
MNB and the favorable clinical course of infected patients
was remarkably similar to that observed in the present study.
The low incidence of peritoneal fluid infection reported in
these studies should not overshadow the importance of
diagnostic fluid studies in the inpatient or ambulatory out-
patient setting under other circumstances. For example, pa-
tients with cirrhosis and new-onset ascites, acute decom-
pensation of liver disease, or signs and symptoms of
peritonitis should undergo expedient evaluation of ascitic
fluid to exclude potentially serious and life-threatening in-
fection. In clinical practice, patients requiring therapeutic
LVP may present with less ominous but concerning symp-
toms of vague abdominal discomfort, mild tenderness on
exam, or subtle changes in affect that may be suggestive of
occult infection. It would be reasonable in such instances of
clinical uncertainty to obtain ascitic fluid cell count with
differential. This approach would rapidly screen for SBP
and CNNA, which require immediate intervention without
the additional expense of cultures. However, if the ascitic
fluid were cloudy at the time of therapeutic paracentesis, it
would be prudent to obtain not only cell counts but a
bacterial culture as well.
Our study results demonstrate that unsuspected ascitic
fluid infection in asymptomatic outpatients with refractory







Outcome of Patients With
Positive Cultures
Sternet al. (21)* 0% 0% (0/37)
Kolle et al. (22) 0% 2.3% (4/173) No treatment or sequelae
Jeffrieset al.† 0% 2.5% (3/118) No treatment or sequelae
* Includes only patients in whom both cell count and culture results were reported.
† Current publication.
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ascites is uncommon (2–3%). Because the outcome of pa-
tients with asymptomatic MNB was favorable and compa-
rable to that reported in the literature, minimal risk would be
incurred if ascitic fluid cultures were not routinely per-
formed. Furthermore, with estimated charges of $240 per
procedure for diagnostic fluid studies (Medicare reimburse-
ment of $32), it would cost;$9600 (Medicare reimburse-
ment of $1320) to diagnose each case of asymptomatic
MNB in a comparable patient population (Table 4). Al-
though further studies are needed, the routine culture of
ascitic fluid in asymptomatic outpatients frequently receiv-
ing prophylactic antibiotics may not be necessary when
there is a low index of suspicion for occult infection. In
circumstances of clinical uncertainty, however, obtaining an
ascitic fluid cell count with differential is recommended to
insure patient safety.
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